NCT00883415 Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease Status COMPLETED Phase N/A
NCT00883181 A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy Status COMPLETED Phase N/A
NCT00872729 Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis Status COMPLETED Phase PHASE1/PHASE2
NCT00872014 A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer Status COMPLETED Phase PHASE2
NCT00869284 Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas Status COMPLETED Phase PHASE2
NCT00866359 A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease Status COMPLETED Phase PHASE2
NCT00865709 Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects Status COMPLETED Phase PHASE2
NCT00863460 Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00861419 To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. Status COMPLETED Phase PHASE1
NCT00861224 Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology Status COMPLETED Phase N/A
NCT00858377 A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00858364 Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Status TERMINATED Phase PHASE3
NCT00853372 AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib Status COMPLETED Phase PHASE2
NCT00848354 Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy Status COMPLETED Phase PHASE4
NCT00842257 Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00841789 A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease Status COMPLETED Phase PHASE2
NCT00840333 "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" Status COMPLETED Phase PHASE1
NCT00838201 Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00838097 European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa Status COMPLETED Phase N/A